SGHT Q2 2024 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SGHTSight Sciences, Inc.

$224M

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$21M-9.0% YoY

Gross Profit

$18M85.8% margin

Operating Income

-$13M-59.2% margin

Net Income

-$12M-57.7% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

+10.9%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$150M

Total Liabilities

$48M

Stockholders' Equity

$102M

Cash & Equivalents

$118M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$23M	-9.0%
Gross Profit	$18M	$20M	-8.7%
Operating Income	-$13M	-$15M	+16.7%
Net Income	-$12M	-$15M	+16.4%

Revenue Segments

Surgical Glaucoma

$20M95%

Dry Eye

$1M5%